๐Ÿšง ๊ตฌ์ถ• ์ค‘ โ€” ๋ฐ์ดํ„ฐ๊ฐ€ ๋ถ€์ •ํ™•ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋” ๋งŽ์€ ๊ธฐ์—…๊ณผ ์ง€ํ‘œ๋ฅผ ์ถ”๊ฐ€ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

Regeneron Pharmaceuticals, Inc. vs Moody's Corporation

์‹œ๊ฐ„์— ๋”ฐ๋ฅธ ์‹œ๊ฐ€์ด์•ก ๋น„๊ต

Regeneron Pharmaceuticals, Inc.

$81.5B

์ˆœ์œ„ #193

Moody's Corporation

$82.6B

์ˆœ์œ„ #191

์‹œ๊ฐ„์— ๋”ฐ๋ฅธ ์‹œ๊ฐ€์ด์•ก

์ฃผ์š” ์ˆœ๊ฐ„

  • Regeneron Pharmaceuticals, Inc.์ด(๊ฐ€) 1995๋…„๊นŒ์ง€ Moody's Corporation์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Moody's Corporation์ด(๊ฐ€) 1997๋…„๊นŒ์ง€ Regeneron Pharmaceuticals, Inc.์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Regeneron Pharmaceuticals, Inc.์ด(๊ฐ€) 2000๋…„๊นŒ์ง€ Moody's Corporation์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Moody's Corporation์ด(๊ฐ€) 2002๋…„๊นŒ์ง€ Regeneron Pharmaceuticals, Inc.์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Regeneron Pharmaceuticals, Inc.์ด(๊ฐ€) 2011๋…„๊นŒ์ง€ Moody's Corporation์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Moody's Corporation์ด(๊ฐ€) 2019๋…„๊นŒ์ง€ Regeneron Pharmaceuticals, Inc.์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Regeneron Pharmaceuticals, Inc.์ด(๊ฐ€) 2020๋…„๊นŒ์ง€ Moody's Corporation์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Moody's Corporation์ด(๊ฐ€) 2021๋…„๊นŒ์ง€ Regeneron Pharmaceuticals, Inc.์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Regeneron Pharmaceuticals, Inc.์ด(๊ฐ€) 2022๋…„๊นŒ์ง€ Moody's Corporation์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Moody's Corporation์ด(๊ฐ€) 2024๋…„๊นŒ์ง€ Regeneron Pharmaceuticals, Inc.์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค

์—ฐ๋„๋ณ„ ๋น„๊ต

์—ฐ๋„Regeneron Pharmaceuticals, Inc.Moody's Corporation์„ ๋‘
2026$81.5B$82.6BMoody's Corporation
2025$79.3B$88.8BMoody's Corporation
2024$72.8B$81.7BMoody's Corporation
2023$89.7B$66.9BRegeneron Pharmaceuticals, Inc.
2022$73.7B$47.2BRegeneron Pharmaceuticals, Inc.
2021$64.5B$65.6BMoody's Corporation
2020$49.4B$48.4BRegeneron Pharmaceuticals, Inc.
2019$38.4B$39.3BMoody's Corporation
2018$38.2B$22.9BRegeneron Pharmaceuticals, Inc.
2017$38.4B$23.9BRegeneron Pharmaceuticals, Inc.
2016$37.5B$15.1BRegeneron Pharmaceuticals, Inc.
2015$55.5B$15.8BRegeneron Pharmaceuticals, Inc.
2014$41.9B$14.9BRegeneron Pharmaceuticals, Inc.
2013$28.1B$12.0BRegeneron Pharmaceuticals, Inc.
2012$17.5B$7.6BRegeneron Pharmaceuticals, Inc.
2011$5.7B$5.0BRegeneron Pharmaceuticals, Inc.
2010$3.4B$3.9BMoody's Corporation
2009$2.5B$3.9BMoody's Corporation
2008$1.9B$2.8BMoody's Corporation
2007$2.5B$5.0BMoody's Corporation
2006$2.1B$9.6BMoody's Corporation
2005$1.6B$8.5BMoody's Corporation
2004$941.1M$6.0BMoody's Corporation
2003$1.5B$4.2BMoody's Corporation
2002$1.9B$2.8BMoody's Corporation
2001$2.9B$2.7BRegeneron Pharmaceuticals, Inc.
2000$3.6B$1.7BRegeneron Pharmaceuticals, Inc.
1999$1.3B$1.5BMoody's Corporation
1998$753.6M$1.6BMoody's Corporation
1997$874.9M$1.6BMoody's Corporation
1996$1.6B$1.2BRegeneron Pharmaceuticals, Inc.
1995$1.3B$1.2BRegeneron Pharmaceuticals, Inc.
1994$306.5M$1.1BMoody's Corporation